Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
Condition: Healthy VolunteersInterventions: Biological: NoV GI.1/GII.4 Bivalent VLP Vaccine; Biological: NoV vaccine placeboSponsor: TakedaNot yet recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2016 Category: Research Source Type: clinical trials